High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Summary: Up to 20% of Crohn's disease (CD) patients respond poorly to glucocorticoids (GC). A product of an alternative splicing of the glucocorticoid receptor (GR) premRNA, GRβ, may play a role as a dominant inhibitor of the glucocorticoid response. Increasing evidence suggests that inflammatory cytokines such as interleukin (IL)-18 alternate the splicing of the primary transcript between the two isoforms GRβ and GRα in hGR gene of CD patients. The aim of this study is to assess the expression of GRα and GRβ in patients with CD and to look for a possible correlation between these receptors and the response to glucocorticoid treatment. Forty-two CD patients and 17 healthy volunteers were studied. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed using real-time PCR techniques. Serum IL-18 protein levels were measured by enzyme-linked immunosorbent assay (ELISA). The amount of hGRα-mRNA in patients in remission was significantly lower than in controls (P < 0·05). The amount of hGRβ-mRNA was significantly higher in GC-resistant patients in the active stage of disease compared with all other groups (P < 0·05). Patients in the active stage of the disease had higher levels of IL-18 than patients in remission and both had higher levels than controls (P < 0·05). The amounts of IL-18 were directly correlated with the amount of hGRβ mRNA in GC-resistant patients with an active disease. High levels of hGRβ might be connected to GC resistance. IL-18 might participate in the alternative splicing of the hGR preliminary mRNA of CD patients. The results support the theory that augmented hGRβ mRNA expression level in PBMC is connected with GC-resistance of CD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642
Cited by
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
Sternberg, E. M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1810 · Cited by 1,064
Inflammation as a psychophysiological biomarker in chronic psychosocial stress
Hänsel, A., Hong, S., Cámara, R. J. A., & von Känel, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.012 · Cited by 457
Guerrero, J., Gatica, H. A., Rodríguez, M., Estay, R., & Goecke, I. A. (2013) · Critical Care · doi:10.1186/cc12774 · Cited by 71
“A change in the expression of the GR isoforms with greater GRb expression has been proposed as a mechanism of GC resistance in chronic inflammatory conditions such as rheumatoid arthritis, ulcerative colitis and others [38-47].”
BackgroundDuBois, D. C., Sukumaran, S., Jusko, W. J., & Almon, R. R. (2013) · Steroids · doi:10.1016/j.steroids.2012.11.014 · Cited by 34
Metadata
- Authors
- Towers, R., Naftali, T., Gabay, G., Carlebach, M., Klein, A., & Novis, B.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-16
- Volume
- 141
- Issue
- 2
- Pages
- 357-362
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W1988948608
- Cited by
- 52
- References
- 1
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance. https://app.cochat.ai/papers/10.1111/j.1365-2249.2005.02846.x
- The paper
- Towers, R., Naftali, T., Gabay, G., Carlebach, M., Klein, A., & Novis, B. (2005). High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance. Clinical and Experimental Immunology. https://doi.org/10.1111/j.1365-2249.2005.02846.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.